Victrex (LON:VCT) Given New GBX 1,050 Price Target at Canaccord Genuity Group

Victrex (LON:VCT) had its target price hoisted by Canaccord Genuity Group from GBX 725 to GBX 1,050 in a research note issued to investors on Tuesday morning, Marketbeat Ratings reports. Canaccord Genuity Group currently has a buy rating on the stock.

Several other analysts have also issued reports on VCT. JPMorgan Chase & Co. increased their price target on shares of Victrex from GBX 625 to GBX 785 and gave the stock a “neutral” rating in a research report on Thursday, September 10th. Jefferies Financial Group restated a “hold” rating and set a GBX 595 price objective on shares of Victrex in a research report on Friday, September 25th. Citigroup upped their target price on Victrex from GBX 700 to GBX 1,000 and gave the stock a “neutral” rating in a research note on Friday, September 11th. Finally, Berenberg Bank raised their target price on Victrex from GBX 680 to GBX 870 and gave the company a “hold” rating in a report on Friday, September 11th. One investment analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of GBX 807.86.

Victrex Price Performance

Shares of LON:VCT opened at GBX 915 on Tuesday. The firm has a 50 day moving average of GBX 855.13 and a 200-day moving average of GBX 699.67. The stock has a market capitalization of £797.48 million, a PE ratio of -40.85, a PEG ratio of 1.92 and a beta of 0.82. The company has a current ratio of 2.35, a quick ratio of 1.99 and a debt-to-equity ratio of 21.30. Victrex has a 12 month low of GBX 515 and a 12 month high of GBX 1,024.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.